Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $43.48M.
ENTERPRISE VALUE (EV)
$43.48M
Pulmonx Corporation
Market Cap
$75.18M
Enterprise Value (EV)
$43.48M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pulmonx Corporation (LUNG) | $75.18M | $43.48M |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | $236.95M |
| Outset Medical, Inc. (OM)vs › | $76.74M | $146.19M |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | $43.22M |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | $69.88M |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | $75.89M |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | $62.93M |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | $54.55M |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | $76.89M |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | N/A |
Market Cap
$75.18M
Total Debt
$38.30M
Cash
$70.01M
Enterprise Value
$43.48M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
